Session Information
ASHP Summer Meeting 2007
Click here to go to the previous page
Developing Evidence-Based Criteria and Strategies for Safe and Appropriate Use of IGIV (Evidence-Based Practice Applications Series)
Track:
Educational Sessions
Program Code: 123-L01
Date: Tuesday, June 26, 2007
Time: 8:00 AM to 10:00 AM
Location:
3016
SPEAKER(S):
Erin C. Hendrick, PharmD, MS, Clinical Pharmacy Coordinator, University of Colorado Hospital, Denver
Jerry Siegel, Pharm.D., Senior Director of Pharmaceutical Services, The Ohio State University Medical Center
Description
This workshop will focus on how to assess the utilization of IGIV at a specific institution and how to develop MUE criteria that will be supported by evidence-based literature. A combination of presentation, discussion, and active participation, this session will present systems for monitoring adverse events as well as prospective utilization management. Participants will discuss product selection criteria for institution and patient specific decisions.